Clinical Trial

The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective cohort study is to investigate whether antithrombotic therapy in the secondary prevention of ischemic stroke increases the risk of the emerging CMBs and whether the change is associated with an increased risk of intracranial hemorrhage, providing an imaging evidence for individualized antithrombotic therapy in such patients.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2018-06-17; most recent amendment 2026-04-22.
Status change: Not Yet Recruiting → Recruiting 2018-09-11
Trial Details
NCT Number NCT03571763
Lead Sponsor General Hospital of Shenyang Military Region
Conditions Ischemic Stroke
Enrollment 1,875 participants
Start Date 2018-08-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-27